InMed Pharmaceuticals Inc...

NASDAQ: INM · Real-Time Price · USD
2.33
-0.01 (-0.43%)
At close: Aug 15, 2025, 1:09 PM

InMed Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
PE Ratio
-0.37 -0.43 -0.55 -4.19
PEG Ratio
0.00 0.00 0.06 0.22
PS Ratio
0.61 0.83 9.39 n/a
PB Ratio
0.42 0.38 1.45 5.79
P/FCF Ratio
-0.55 -0.61 -0.84 -4.36
P/OCF Ratio
-0.55 -0.62 -0.85 -4.37
OCF/S Ratio
-1.11 -1.33 -11.11 n/a
Debt / Equity Ratio
0.10 0.03 0.09 0.04
Quick Ratio
3.78 4.86 2.14 435.23
Current Ratio
4.41 5.66 2.89 3.78
Asset Turnover
0.53 0.39 0.11 n/a
Interest Coverage
n/a n/a n/a -27.54
Return on Equity
-1.14 -0.87 -2.64 -1.38
Return on Assets
-0.89 -0.75 -1.87 -1.04
Return on Invested Capital
-1.1 -0.89 -1.8 -1.34
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.24 0.34 0.50 n/a
Net Profit Margin
-1.67 -1.92 -17.07 n/a
Pretax Profit Margin
-1.67 -1.92 -17.07 n/a
Operating Profit Margin
-1.77 -2.03 -12.66 n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.64 -1.88 -12.19 n/a